172 related articles for article (PubMed ID: 38557247)
1. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
Zhu Z; Han Y; Gong M; Sun B; Zhang R; Ding Q
J Virol; 2024 May; 98(5):e0195723. PubMed ID: 38557247
[TBL] [Abstract][Full Text] [Related]
2. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.
Kim GN; Choi JA; Wu K; Saeedian N; Yang E; Park H; Woo SJ; Lim G; Kim SG; Eo SK; Jeong HW; Kim T; Chang JH; Seo SH; Kim NH; Choi E; Choo S; Lee S; Winterborn A; Li Y; Parham K; Donovan JM; Fenton B; Dikeakos JD; Dekaban GA; Haeryfar SMM; Troyer RM; Arts EJ; Barr SD; Song M; Kang CY
PLoS Pathog; 2021 Dec; 17(12):e1010092. PubMed ID: 34914812
[TBL] [Abstract][Full Text] [Related]
3. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
4. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
5. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Smith BK; Shrihari S; McCune BT; Harvey IB; Keeler SP; Bloyet LM; Zhao H; Ma M; Adams LJ; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
Cell Host Microbe; 2020 Sep; 28(3):465-474.e4. PubMed ID: 32798445
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.
Case JB; Rothlauf PW; Chen RE; Liu Z; Zhao H; Kim AS; Bloyet LM; Zeng Q; Tahan S; Droit L; Ilagan MXG; Tartell MA; Amarasinghe G; Henderson JP; Miersch S; Ustav M; Sidhu S; Virgin HW; Wang D; Ding S; Corti D; Theel ES; Fremont DH; Diamond MS; Whelan SPJ
Cell Host Microbe; 2020 Sep; 28(3):475-485.e5. PubMed ID: 32735849
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.
Havranek KE; Jimenez AR; Acciani MD; Lay Mendoza MF; Reyes Ballista JM; Diaz DA; Brindley MA
Viruses; 2020 Dec; 12(12):. PubMed ID: 33353101
[TBL] [Abstract][Full Text] [Related]
8. Broad Cross-Species Infection of Cultured Cells by Bat HKU2-Related Swine Acute Diarrhea Syndrome Coronavirus and Identification of Its Replication in Murine Dendritic Cells
Yang YL; Qin P; Wang B; Liu Y; Xu GH; Peng L; Zhou J; Zhu SJ; Huang YW
J Virol; 2019 Dec; 93(24):. PubMed ID: 31554686
[TBL] [Abstract][Full Text] [Related]
9. TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus.
Han Y; Ma Y; Wang Z; Feng F; Zhou L; Feng H; Ma J; Ye R; Zhang R
J Med Virol; 2024 Jun; 96(6):e29712. PubMed ID: 38808555
[TBL] [Abstract][Full Text] [Related]
10. Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.
Li H; Zhao C; Zhang Y; Yuan F; Zhang Q; Shi X; Zhang L; Qin C; Zheng A
Emerg Microbes Infect; 2020 Dec; 9(1):2269-2277. PubMed ID: 32990161
[TBL] [Abstract][Full Text] [Related]
11. Functional dissection of the spike glycoprotein S1 subunit and identification of cellular cofactors for regulation of swine acute diarrhea syndrome coronavirus entry.
Yang Y-L; Wang B; Li W; Cai H-L; Qian Q-Y; Qin Y; Shi F-S; Bosch B-J; Huang Y-W
J Virol; 2024 Apr; 98(4):e0013924. PubMed ID: 38501663
[TBL] [Abstract][Full Text] [Related]
12. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Elife; 2020 Oct; 9():. PubMed ID: 33112236
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins.
Lay Mendoza MF; Acciani MD; Levit CN; Santa Maria C; Brindley MA
Viruses; 2020 Dec; 12(12):. PubMed ID: 33348746
[TBL] [Abstract][Full Text] [Related]
14. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.
Kapadia SU; Simon ID; Rose JK
Virology; 2008 Jun; 376(1):165-72. PubMed ID: 18396306
[TBL] [Abstract][Full Text] [Related]
15. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
[TBL] [Abstract][Full Text] [Related]
16. Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.
Xiong HL; Wu YT; Cao JL; Yang R; Liu YX; Ma J; Qiao XY; Yao XY; Zhang BH; Zhang YL; Hou WH; Shi Y; Xu JJ; Zhang L; Wang SJ; Fu BR; Yang T; Ge SX; Zhang J; Yuan Q; Huang BY; Li ZY; Zhang TY; Xia NS
Emerg Microbes Infect; 2020 Dec; 9(1):2105-2113. PubMed ID: 32893735
[TBL] [Abstract][Full Text] [Related]
17. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins.
Fukushi S; Watanabe R; Taguchi F
Methods Mol Biol; 2008; 454():331-8. PubMed ID: 19057867
[TBL] [Abstract][Full Text] [Related]
18. Recombinant vesicular stomatitis virus expressing the spike protein of genotype 2b porcine epidemic diarrhea virus: A platform for vaccine development against emerging epidemic isolates.
Ke Y; Yu D; Zhang F; Gao J; Wang X; Fang X; Wang H; Sun T
Virology; 2019 Jul; 533():77-85. PubMed ID: 31128495
[TBL] [Abstract][Full Text] [Related]
19. A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization.
Liu R; Wang J; Shao Y; Wang X; Zhang H; Shuai L; Ge J; Wen Z; Bu Z
Antiviral Res; 2018 Feb; 150():30-38. PubMed ID: 29246504
[TBL] [Abstract][Full Text] [Related]
20. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
